Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut) - Greiner, Jochen; Schneider, Vanessa; Schmitt, Michael; Götz, Marlies; Döhner, Konstanze; Wiesneth, Markus; Döhner, Hartmut; Hofmann, Susanne (Blood, 2013)
Gesehen am 25.02.2020